James O. McNamara

Director, Center for Translational Neuroscience at Duke University - School of Medicine

James O. McNamara

James O. McNamara

Director, Center for Translational Neuroscience at Duke University - School of Medicine

Overview
Career Highlights

American Epilepsy Society
NeurOp, Inc.
Duke Center for the Advanced Study of Epilepsy

RelSci Relationships

826

Number of Boards

3

Relationships
RelSci Relationships are individuals James O. McNamara likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at NeurOp, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at NeurOp, Inc.

Relationship likelihood: Strong

President Emeritus at The Wistar Institute

Relationship likelihood: Strong

Founding Director for the Center for Applied Genomics & Precision Medicine at Duke University - School of Medicine

Relationship likelihood: Strong

Principal Deputy Commissioner at U.S. Food and Drug Administration

Relationship likelihood: Strong

Co-Founder at Altiris Therapeutics, Inc.

Relationship likelihood: Strong

Operating Partner at Centre Partners Management LLC

Relationship likelihood: Strong

Medical Director, Primary Care Site-Based Research Group at Duke University - Medical Center

Relationship likelihood: Strong

President & Chief Executive Officer at Galectin Therapeutics, Inc.

Relationship likelihood: Strong

Venture Advisor at Pappas Capital LLC

Relationship likelihood: Strong

Paths to James O. McNamara
Potential Connections via
Relationship Science
You
James O. McNamara
Director, Center for Translational Neuroscience at Duke University - School of Medicine
Education
MD
Class of 1968

University of Michigan founded its medical school in 1850, it immediately assumed a leadership role in American academic medicine. Medical School was the University's first professional school, and since graduating its first class of six students in 1851 a group which paid a mere $5 for two years of medical education. They have become a leader in preparing the physicians and scientists of the future.

The University of Michigan (UM, U-M, UMich, or U of M), frequently referred to as simply Michigan, is a public research university located in Ann Arbor, Michigan, United States. It is the state's oldest university and the flagship campus of the University of Michigan. It is one of the original eight Public Ivy universities and is one of the founding members of the Association of American Universities. It has been ranked among the top five research universities in the US, and among the top 20 universities in the world. U-M also has satellite campuses in Flint and Dearborn.

Unknown

Marquette is a Catholic and Jesuit university in Milwaukee, Wis., dedicated to serving God by serving our students and contributing to the advancement of knowledge. Enrollment: Almost 8,300 undergraduate and 3,500 graduate and professional students; all states and 69 countries represented Undergraduate programs: 77 majors and 65 minors and pre-professional programs in dentistry, law and medicine

Career History
Co-Founder
2002 - Current

NeurOp, Inc. manufactures and distributes pharmaceutical products. It operates as a biopharmaceutical company which develops new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia, schizophrenia, and Alzheimer's and Parkinson's diseases. The company was founded by Raymond Dingledine, James McNamara and Stephen Traynelis in 2002 and is headquartered in Atlanta, GA.

Professional
Prior

Smithkline Diagnostics, Inc., a subsidiary of GlaxoSmithKline Plc, is a company headquartered in the United States specializing in laboratory analytical instruments.

Advisor
Current

Pappas Ventures invests exclusively in the life sciences sector including biotechnology, specialty pharmaceuticals, diagnostics, drug delivery, medical devices and and other related ventures. They typically pursue early- to mid-stage investments. The firm places emphasis on companies with products or technologies at the pre-clinical, Phase 1 or Phase 2 stage of development. They invest across the spectrum of start-up companies to well-established companies.Pappas Ventures focuses on the quality and experience of a potential portfolio company's management team. They look for management teams with a proven track record, the ability to communicate the company's story to a variety of audiences and a deep commitment to creating shareholder value. The firm also seeks companies with a strong proprietary position, a large clearly-defined market and a realistic exit strategy.About one-third of their investments are made in California and about one-third are made in companies on the East Coast of the US including the Research Triangle area of North Carolina. The remaining capital is invested in underserved regions such as Texas, Indiana and Montreal.The firm invest anywhere from a seed deal to a later-stage mezzanine transaction.

Boards & Committees
Chairman
2002 - Current

NeurOp, Inc. manufactures and distributes pharmaceutical products. It operates as a biopharmaceutical company which develops new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia, schizophrenia, and Alzheimer's and Parkinson's diseases. The company was founded by Raymond Dingledine, James McNamara and Stephen Traynelis in 2002 and is headquartered in Atlanta, GA.

Member, Scientific Advisory Board
Current

Pappas Ventures invests exclusively in the life sciences sector including biotechnology, specialty pharmaceuticals, diagnostics, drug delivery, medical devices and and other related ventures. They typically pursue early- to mid-stage investments. The firm places emphasis on companies with products or technologies at the pre-clinical, Phase 1 or Phase 2 stage of development. They invest across the spectrum of start-up companies to well-established companies.Pappas Ventures focuses on the quality and experience of a potential portfolio company's management team. They look for management teams with a proven track record, the ability to communicate the company's story to a variety of audiences and a deep commitment to creating shareholder value. The firm also seeks companies with a strong proprietary position, a large clearly-defined market and a realistic exit strategy.About one-third of their investments are made in California and about one-third are made in companies on the East Coast of the US including the Research Triangle area of North Carolina. The remaining capital is invested in underserved regions such as Texas, Indiana and Montreal.The firm invest anywhere from a seed deal to a later-stage mezzanine transaction.

Member, Advisory Committee
Current
Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$500 - $2,499
2012

American Epilepsy Society is a nonprofit company headquartered in West Hartford, CT. The firm operates as non-profit organisation for professionals dedicated to the prevention and treatment of epilepsy.

Political Donations
$100
2008

Chief Executive Officer, Treasurer & Director at First Bancorp - North Carolina

Investments
Details Hidden

NeurOp, Inc. manufactures and distributes pharmaceutical products. It operates as a biopharmaceutical company which develops new medicines for central nervous system disorders, including depression, neuropathic pain, ischemia, schizophrenia, and Alzheimer's and Parkinson's diseases. The company was founded by Raymond Dingledine, James McNamara and Stephen Traynelis in 2002 and is headquartered in Atlanta, GA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by James O. McNamara. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of James O. McNamara's profile does not indicate a business or promotional relationship of any kind between RelSci and James O. McNamara.